Medicover Stock

Medicover PEG

The PEG Ratio (Price/Earnings-to-Growth) of Medicover (MCOV B.ST) as of Aug 4, 2026 is 0.45. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 2.08 — a change of -78.45% (lower).

PEG

0.45

YoY

-78.45%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Medicover is 2026 0.45 . PEG Ratio (Price/Earnings-to-Growth) of Medicover was 2025 2.08 . It decreases by -78.45% lower compared to the previous year.
Access this data via the Eulerpool API

Medicover Stock analysis

What does Medicover do? Medicover AB is a leading healthcare company in Europe with its headquarters in Stockholm, Sweden. The company was founded in 1995 by Fredrik Rågmark with the aim of providing high-quality medical care for patients. Medicover's business model is based on an integrated chain of healthcare services. This includes doctor's offices, specialists, diagnostic centers, hospitals, laboratories, health centers, and nursing services. The company operates in Poland, Romania, Hungary, Germany, Ukraine, and Belarus, and offers a wide range of healthcare services. The main sectors of Medicover include healthcare services for individuals and businesses, as well as the use of cutting-edge technologies and data analysis to improve patient care. The company offers a variety of services in the areas of prevention, diagnosis, and therapy, including laboratory tests, imaging, health checks, medical advice, and treatment of acute and chronic diseases. In the field of corporate services, Medicover offers occupational medicine, corporate health management, as well as health programs and training for employees of companies. This helps promote the health and well-being of employees while achieving higher productivity and efficiency. Products offered by Medicover include insurance services, hospital services, travel medicine, vaccinations, child care, and family planning. The company also offers specialized programs for patients with chronic diseases such as diabetes, hypertension, and cardiovascular diseases. An important component of Medicover's business model is the use of data analysis and technology to improve patient care. The company leverages the latest innovations in medical technology such as telemedicine, electronic health records, and mobile applications to enable faster and more effective access to healthcare. With a strong focus on quality and customer satisfaction, Medicover has become one of the leading healthcare companies in Europe. The company employs over 25,000 employees and serves over 6 million patients per year. In summary, Medicover is an innovative and integrated company in the healthcare industry, specializing in providing high-quality healthcare services and utilizing advanced technologies and data analysis to improve patient care. Medicover is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicover stock

PEG Ratio (Price/Earnings-to-Growth) of Medicover is 0.45 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Medicover changed from 2.08 to 0.45, representing a -78.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Medicover since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Medicover with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Medicover

All Key Metrics — Medicover